Healthcare Industry Insights

Monday, 18 October 2021

Livestock Monitoring Market Size Worth $13.50 Billion By 2028

The global Livestock Monitoring Market size is expected to reach USD 13.50 billion by 2028, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 16.56% from 2021 to 2028. An increase in the population of livestock animals, coupled with the farmer’s focus on increasing yield and productivity, is the key contributor to the market growth.

The key advantages of livestock monitoring such as milk harvesting, feeding management, animal health monitoring, and behavior monitoring are anticipated to drive the market. Furthermore, there is an increase in the adoption of internet of things (IoT) and artificial intelligence (AI) by livestock farmers. This is due to an increase in internet penetration and widespread technological advancement.

There is an increased demand for animal products and thus several countries are focusing on livestock rearing. This has led to an increase in the livestock population. In addition, a prevalence of zoonotic diseases is fueling the growth of the market. This is because these disease outbreaks in the livestock can be major socioeconomic threats, resulting in production loss and disruption of local markets, rural economy, and international trade. Factors like these are expected to encourage the adoption of livestock monitoring systems among livestock owners.

The COVID-19 pandemic has triggered an unexpected crisis in the general agricultural processing industries and the processing of dairy products. The onset of the pandemic has caused tremendous economic losses to the beef, pork, poultry, and dairy industries worldwide. As the COVID-19 virus spread across the globe, several industries evaluated its impact on their businesses. Given the increased demand for goods as consumers stocked up for possible quarantines or restricted their visits to the grocery stores, companies faced challenges to cope with the increasing demand and protect the supply chain. However, with the improving situations, the market is expected to witness growth in the coming years.

Industry players are involved in strategies including mergers & acquisitions, collaborative agreements, and geographic expansion to gain an edge over the competition. For instance, in February 2021, Fancom announced an enhanced version of the light control for Lumina 38H and 36/38 poultry computers. In another instance, in February 2021, MSD Animal Health announced the acquisition of PrognostiX Poultry Limited, a provider of health and environmental monitoring solutions for the poultry business, which expanded its product portfolio.

Related Press Release@ Livestock Monitoring Market Report

Livestock Monitoring Market Report Highlights

The cattle animal type segment held the largest share of over 45.0% in 2020 owing to the rising demand for beef and dairy products
The software component segment is expected to witness the fastest growth over the forecast period. This is because the software has promoted interoperability between different data management systems and ultimately added value for customers
The feeding management application segment accounted for the largest revenue share of more than 27.0% in 2020. This can be attributed to the high demand for feeding management to monitor the food intake of the animal
North America dominated the market with a revenue share of over 31.0% in 2020 due to the presence of well-established companies and technologically advanced infrastructure
Asia Pacific is anticipated to witness the fastest growth over the forecast period owing to the presence of the high potential and rapidly growing economies, including India, Japan, and China, in this region

List of Key Players of Livestock Monitoring Market

· DeLaval Inc

· GEA Group Aktiengesellschaft Ottobock

· Afimilk Ltd.

· Sensaphone

· BouMatic

· MSD Animal Health

· Dairymaster

· Fancom BV

· Lely

· Fullwood Packo

About Us:

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.

Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415- 349-0058
Toll Free: 1-888- 202-9519
Email: sales@grandviewresearch.com
For More Information: https://www.grandviewresearch.com

Flow Diverters Market by Medtronic, Stryker Corporation, MicroVention, Inc. (Terumo Corporation)

The global Flow Diverters Market size is anticipated to reach USD 874.10 million by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 16.9% from 2021 to 2028. Increasing research activities pertaining to the treatment of brain aneurysm and the rising prevalence of cerebral aneurysm are driving the market.

An increasing number of patients suffering from hypertension significantly increases the risk of a brain aneurysm. This is expected to drive market growth in the coming years. Hypertension or trauma to blood vessels is the major cause of brain aneurysm. As per the WHO facts 2019, around 1.1 billion people worldwide are suffering from hypertension.

In addition, several initiatives launched by the government of various countries to improve public awareness and treatment related to cerebral aneurysm are driving the market. For instance, the Brain Aneurysm Foundation of Canada works toward educating and spreading awareness about brain aneurysms. This program includes early access to monthly educational webinars and social media campaigns for highlighting the prevalence of brain aneurysms.

Moreover, companies are developing and launching technologically advanced products for attracting more customers in the market. For instance, in January 2020, MicroVention, Inc., (part of Terumo Corporation) received the U.S. FDA Premarket Approval for its FRED to treat intracranial aneurysms. It utilizes self-expanding, woven nitinol mesh to re-direct blood flow and promote aneurysm occlusion.

Related Press Release@: Flow Diverters Market Report

Flow Diverters Market Report Highlights

On the basis of diameter size, the >5 mm flow diverters segment dominated the overall market with a share of 65.8% in 2019 owing to their increasing demand and application in treating giant and wide intracranial aneurysms (>10 mm vessel diameter)
North America dominated the market with the highest revenue share of 46.5% in 2019 owing to the high prevalence rate of brain aneurysms and the presence of key market players in this region
In Asia Pacific, the market is expected to witness the highest CAGR of 14.4% from 2020 to 2027 owing to the presence of a huge target population and increasing healthcare spending in the region

About Us:
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.

Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415- 349-0058
Toll Free: 1-888- 202-9519
Email: sales@grandviewresearch.com
For More Information: https://www.grandviewresearch.com

Sunday, 17 October 2021

Large Molecule Bioanalytical Testing Services Market Worth $3.0 Billion By 2028

The global Large Molecule Bioanalytical Testing Services Market size is expected to reach USD 3.0 billion by 2028, according to a new study by Grand View Research, Inc. It is expected to expand at a CAGR of 9.5% from 2021 to 2028. The major factor attributing to market growth is the increased application of bioanalytical testing in clinical trials of biomarkers, large molecules, and others.

Rising prevalence of HIV, infectious disease, and others has led to increasing demand for bioanalytical testing services globally. Moreover, increasing government initiatives to control the outbreak of various infectious diseases such as Corona and Ebola virus is anticipated to offer more opportunities for the market. Hence, the market is expected to grow over the assessment period.

The market is expected to witness lucrative growth during the forecast period due to increased research activities and the presence of a huge pipeline of peptides, biologics, and amino acids based molecules. Additionally, bioanalysis of large molecules requires skilled professionals with innovative analytical instruments and infrastructure. These services are readily offered by bioanalytical testing service providers and are likely to propel the growth of the market during the assessment period.

North America accounted for the highest share in 2019. The U.S. holds the highest market share due to the increasing prevalence of various chronic diseases and the growing adoption of large molecule therapeutics as an alternative for small molecules.

For example, according to International Diabetes Federation Report 2019, around 49.0 million geriatric population in the U.S. has diabetes and this has led to increasing requests for bioanalysis of the novel (large molecule compounds) peptide therapeutics such as glucagon-like peptide 1(GLP-1). Due to this reason, the market is expected to show growth over the forecast period. In addition, the presence of major players in the region contributed to market growth.

Related Press Release@ Large Molecule Bioanalytical Testing Service Market Report

Large Molecule Bioanalytical Testing Services Market Report Highlights

By type, the clinical segment held the largest market share in 2019 owing to increasing demand for clinical trials due to the rising prevalence of various infectious diseases
Bioavailability held the largest market share of 20.9% in 2019 owing to increasing adoption in generic drug manufacturing
The oncology segment held the largest revenue share due to the increasing prevalence of cancer globally
The U.S. is expected to witness the fastest growth over the forecast period owing to the growing adoption of advanced therapeutic techniques in the country.

Thursday, 14 October 2021

Scar Treatment Market Key Players, Industry Share, Growth, And Forecast To 2028

The global Scar Treatment Market size is expected to reach a value of USD 46.3 billion by 2028 registering a CAGR of 10.1%, according to a new report by Grand View Research, Inc. Scar treatment market is developing at a fast rate due to the growing awareness among people regarding aesthetics. Acne scars are one of the most common concerns. Rise in the number of road accidents also results in several marks, which many a time require surgical assistance.

Hence, patients who have undergone such surgeries are generally provided with topical products for scar reduction. Cosmetic surgeries with laser instruments are also being undertaken for treating severe marks from road accidents. To remove such marks, plastic surgeries or resurfacing laser therapies are being preferred. Technologically advanced scar removal products minimize pain and facilitate a hassle-free healing process. For instance, UltraPulse by Lumenis uses CO₂ laser for the treatment of acne scars reduces the risk of pain during the treatment process.

Related Press Release@ Scar Treatment Market Report

Scar Treatment Market Report Highlights

Topical products led the global scar removal treatment market in 2018 due to higher demand for creams and gels for treating scars, such as acne, surgical marks, and burns
Laser products are anticipated to witness the fastest CAGR over the forecast period due to the introduction of technically advanced laser instruments
North America was the dominant regional market in 2018 owing to the high penetration of laser-based products in skin rejuvenation and scar treatment

Regenerative Medicine Market by AstraZeneca plc, F. Hoffmann-La Roche Ltd., Integra Lifesciences Corp.

The global Regenerative Medicine Market size is expected to reach USD 57.08 billion by 2027, growing at a CAGR of 11.27% over the forecast period, according to a new report by Grand View Research, Inc. Recent advancements in biological therapies have resulted in a gradual shift in preference toward personalized medicinal strategies over the conventional treatment approach. This has resulted in rising R&D activities in the regenerative medicine arena for the development of novel regenerative therapies.

Furthermore, advancements in cell biology, genomics research, and gene-editing technology are anticipated to fuel the growth of the industry. Stem cell-based regenerative therapies are in clinical trials, which may help restore damaged specialized cells in many serious and fatal diseases, such as cancer, Alzheimer’s, neurodegenerative diseases, and spinal cord injuries. For instance, various research institutes have adopted Human Embryonic Stem Cells (hESCs) to develop a treatment for Age-related Macular Degeneration (AMD).

Constant advancements in molecular medicines have led to the development of gene-based therapy, which utilizes targeted delivery of DNA as a medicine to fight against various disorders. Gene therapy developments are high in oncology due to the rising prevalence and genetically driven pathophysiology of cancer. The steady commercial success of gene therapies is expected to accelerate the growth of the global market over the forecast period.

Related Press Release@ Regenerative Medicine Market Report

Regenerative Medicine Market Report Highlights

The number of companies engaged in the development of advanced therapies is continuously increasing over the past few years. This is anticipated to increase the competition among companies to create a specific and efficient pipeline
The therapeutics segment dominated the market in 2020 due to the high usage of primary cell-based therapies along with advances in stem cell and progenitor cell therapies. The implementation of these therapies in dermatological, musculoskeletal, and dental application results in the highest share of this segment
Stem cell and progenitor cell-based therapies are anticipated to witness rapid growth due to high investments in this research space and an increasing number of stem cell banks
With the rise in R&D and clinical trials of regenerative medicines, key players are offering several consulting services leading to lucrative growth of the services segment
The oncology segment is estimated to account for the largest revenue share by 2027 owing to the high prevalence of cancer indications, which drives the demand for better solutions. The presence of a strong pipeline of regenerative medicines for cancer treatment also supplements the segment growth
North America dominated the market in 2020 and is projected to continue its dominance over the forecast period. A significant number of universities and research organizations investigating various stem cell-based approaches for regenerative apposition in the U.S. propels the region’s growth
Asia Pacific is projected to witness the fastest CAGR over the forecast period due to the emergence of key players and rapid adoption of cell-based approaches in the healthcare

Medical Device Testing Services Market by SGS SA, Toxikon, Inc., Eurofins Scientific, Pace Analytical Services LLC

The global Medical Device Testing Services Market size is expected to reach USD 18.6 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 11.6% from 2021 to 2028. Increasing complexity in product design and stringent government regulations are driving the market.

A significant rise in preclinical spending is a recent trend among pharmaceutical and medical device companies, which is expected to significantly contribute to market growth. As per a survey carried out by the International Federation of Pharmaceutical Manufacturers and Associations in 2017, around USD 149.8 billion is spent on preclinical trials every year.

With modern medical equipment offering a host of complex functions, the need for appropriate tests to check the compliance of the device with regulatory requirements is becoming vital. In order to meet the requirement of enhanced accuracy, ease of use, and durability, medical devices need to undergo extensive tests. This is expected to deliver a competitive advantage to manufacturers.

The COVID-19 pandemic has created an unprecedented demand for medical device testing services in 2020. This is largely due to the increasing demand for COVID-10 related products such as masks, PPE, and respiratory equipment. Besides, countries such as Mexico, Spain, and France have published pertinent specifications and standards, namely the UNE 0064-1, UNE 0064-2, AFNOR-SPEC-S76 and UNE 0065 which must be met until a mask can be sold.

Related Press Release@ Medical Device Testing Services Market Report

Medical Device Testing Services Market Report Highlights

The microbiology and sterility testing segment dominated the market in 2020 and accounted for the largest revenue share of 34.1%. The segment is likely to remain dominant over the forecast period
Producing safe and effective products is a core goal of medical equipment manufacturers and sterility assurance is a major component for achieving it
The preclinical phase segment dominated the market in 2020 and accounted for 65.7% of the revenue share as this stage is mostly focused on assessing the safety and biocompatibility of medical devices
Raw materials, packaging, and design all have an impact on a device's safety and compatibility, and preclinical testing of all of these factors is an important step in determining a device's market potential
Asia Pacific dominated the market and accounted for 41.8% of the revenue share in 2020. This is due to the rising demand for medical devices in developing nations such as India and China

Life Science Analytics Market Size is Expected to Experience a CAGR of 7.8% till 2028

The global Life Science Analytics Market size is expected to reach USD 14.1 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 7.8% from 2021 to 2028. The growing need to improve patient outcomes and reduce healthcare costs is contributing to the growing demand for life science analytical solutions. The growing demand for personalized medicine and the rising impact of social media and the internet on shaping the healthcare industry are boosting growth. Furthermore, the growing adoption of analytical solutions and the emergence of advanced analytics for the life science industry is further driving the market during the forecast period.

The ongoing Covid-19 pandemic has burdened healthcare systems across the globe and is anticipated to drive the demand for analytics in the life science industry. Technological advancements during the pandemic have enabled healthcare systems to develop solutions to overcome physical limitations of capital and labor and open up new sources of value and growth. For instance, Moderna and IBM utilized artificial intelligence, cloud computing, and blockchain solutions to support Covid-19 vaccine management.

Based on component, the services segment accounted for the largest revenue share in 2020 owing to the increasing trend of outsourcing these services since healthcare and life science companies lack resources and capabilities to deploy analytical software and services. Additionally, the services segment is expected to exhibit the fastest growth during the forecast period owing to multi-package services offered by these outsourced companies.

In 2020, the descriptive type segment accounted for the largest revenue share owing to the growing demand for descriptive and quantifiable analysis using historic data. The growing need of understanding past behavior of consumers and serviceable audience to predict future market dynamics using data mining techniques are contributing to the growth of the descriptive type segment. On the other hand, the predictive type segment is anticipated to register the fastest-growing during the forecast period owing to the increasing adoption of advanced analytics to predict possible future outcomes and aids stakeholders in designing strategies and devise appropriate tactics to sustain and improve performance.

Based on the application, the sales and marketing support segment accounted for the largest revenue share in 2020 owing to the increasing adoption of big data analytics in the sales and marketing vertical of life science companies to attain higher consumer responsiveness and gain consumer insight to enhance sales productivity. On the other hand, the research and development segment is expected to exhibit the fastest growth during the forecast period owing to the growing pipeline of pharmaceutical and medical device companies. In addition, the segment is expected to experience an increase in demand for licensing products and technologies and would eventually contribute to the growth and development of the market.

In 2020, the on-premise delivery segment accounted for the highest revenue share owing to the ease of access from remote locations with minimized costs and maintenance. On the other hand, the on-demand delivery segment is anticipated to grow fast during the forecast period owing to the increasing adoption of cloud computing solutions. In addition, increased usage of the internet and web-based services and its enhanced accessibility from the most remote locations are contributing to segment growth.

Based on end-user, pharmaceutical companies accounted for the largest revenue share in 2020 owing to the rising adoption of analytical software solutions to enhance the efficiency of clinical trials and increase drug utilization. On the other hand, the biotechnology segment is anticipated to grow fast during the forecast period owing to the increasing adoption of analytics in genome analysis and sequencing to curb expenditure. In addition, the availability of personalized data analytic solutions is increasing the growth and development of the segment.

In 2020, North America dominated the market and accounted for the largest revenue share. This can be attributed to the rise in adoption of advanced analytics, growing geriatric population and increasing prevalence of non-communicable diseases, high economic development, and presence of well-equipped infrastructure and facilities. On the other hand, Asia Pacific is expected to be the fastest-growing region during the forecast period owing to infrastructure investments, regional expansion, economic development, and low-cost and highly skilled workforce is boosting the growth of the market in Asia Pacific.

Related Press Release@ Life Science Analytics Market Report

Life Science Analytics Market Report Highlights

The market is anticipated to witness significant growth over the forecast period owing to the increasing adoption of analytics and the emergence of advanced analytics in the life science industry
The services component segment dominated the market in 2020, owing to the growing trend of outsourcing these services
The descriptive type segment dominated the market in 2020, owing to the growing demand for descriptive and quantifiable analysis to understand business scenarios
The sales and marketing support application segment dominated the market in 2020, owing to the increasing adoption of analytical solutions to enhance sales productivity
The on-premise delivery mode segment dominated the market in 2020 owing to the easy accessibility of these solutions from remote locations
The pharmaceutical companies segment dominated the market in 2020 owing to the growing pipeline and need of enhancing clinical trial efficiency and rising demand for personalized medicine
North America dominated the market in 2020 owing to technological advancements in well-equipped facilities